Decarbonizing the chemicals industry
In 2016, we set out to radically transform the chemicals industry. What started as a pledge to first, do no harm, became a promise to bring clean, sustainable chemistry to every industry and every aspect of modern life. In the years since, we’ve opened the world’s first carbon-negative molecule factory and made plans to build many more across the US; we’ve made scalable synthetic biology a reality, and now we’re bringing high performing, cost competitive, carbon-negative products to the whole world.
Areas of expertise
- Formulation
- Application
- Synthesis
- Manufacturing
- Sustainability
- Enzyme Engineering
Learn more about Solugen
See why we started Solugen
Our Values
-
First, do no harm
We exist to reverse climate change. In everything we do and for everyone we affect, we are committed to fostering an environment that is intrinsically safe. For us, that means more than avoiding negative impacts — it means actively seeking out ways to make everything we do better.
-
Think big, act now
We understand that solving the climate crisis requires bold and immediate action. We know that perfection is a myth, and we don’t let fear of failure hold us back. In fact, we believe that when things don’t go as expected, it sometimes provides the ultimate opportunity to achieve a better outcome.
-
Delight customers
Every decision we make is driven by the needs and future success of our customers. Customers will always want something better, and our desire to delight them will drive us to invent. Because it is through them that our business will thrive and scale, enabling us to deliver on our planet-saving mission.
-
Never stop growing
A goal as ambitious as ours requires people who never stop seeking ways to improve themselves and those around them. Our work demands — and our culture fosters — a high trust environment where people feel safe to take risks, push each other outside comfort zones, and never stop learning.
Our Story
A long-standing poker game with a group of University of Texas Southwestern medical students in Dallas brought Gaurab Chakrabarti and Sean Hunt together.
Gaurab, getting his MD/PhD, was researching a drug candidate for pancreatic cancer. Hunt was a grad student at MIT studying chemical engineering. They began discussing how to use enzymes in an industrial, chemical process, and now they have 500,000 sq ft of manufacturing space across two facilities. They are looking forward to taking on the chemicals industry at scale, one molecule at a time.
